You are here

Our science / Clinical Trials / Find a Trial / NCT00245973

Study Evaluating Bifeprunox in Bipolar Depression

Back to Search Print Save as PDF Bookmark Trial

NCT00245973

Last updated on March 14, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Birmingham, Alabama, 35216 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Depression Bipolar
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Men and women 18 to 65 years of age, inclusive.

- Diagnosis of Bipolar Disorder and must be experiencing a depressive episode.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- This is a follow on study to protocol 3168A2-304. Only subjects who have participated
in the previous study are eligible.

NCT00245973
Pfizer
Completed
Study Evaluating Bifeprunox in Bipolar Depression

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Depression Bipolar
Study Evaluating Bifeprunox in Bipolar Depression
NCT00245973
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now